LEUKOLABS is a UK founded network to promote collaboration in leukodystrophy research by bringing together researchers and clinicians to promote translational leukodystrophy research with patient-focused outcomes. It is the first UK leukodystrophy network.
Our partnership with Leukolabs provides optimal opportunities to coordinate new research and improve patient outcomes nationally. As part of our new research strategy in 2023 to support research, we assist Leukolabs to apply for research grants from organisations such as the National Institute for Health and Care Research.
They attend our Community Weekends, providing interesting presentations to update our community on their work and the progress they are making.
To find out more about them, visit their Leukolabs page.
